Miroprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S00I5XG484, chemically known as 4-imidazo(1,2-a)pyridin-2-yl-alpha-methylbenzeneacetic acid but generally known as miroprofen, which bears US NIH Compound Identifier 68752. European Medicines Agency schedules Miroprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08994MIG. The term MIROPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 1, 1999, List 41). MIROPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule miroprofen under HS 29339990 and SITC 51577. As of Q4 2014, MIROPROFEN remains the US FDA Preferred Term for this commodity. Miroprofen bears US NLM identifiers UMLS ID C0066589 and NCI Concept Code C90910. SMILES: OC(=O)C(C1CCC(C2NC3N(C2)CCCC3)CC1)C.